Sarah Ford | September 19, 2013
OCRF Researchers Find Some Immune Cells Aid Cancer Growth
A new OCRF-funded study from researchers at the University of Michigan Comprehensive Cancer Center found that a subset of immune cells, called myeloid derived suppressor cells, do more harm than good by providing a niche where the cancer stem cells survive. The research is published in the journal Immunity.
Cancer stem cells are thought to be resistant to current chemotherapy and radiation treatments, and researchers believe that killing the cancer stem cells is crucial for eliminating cancer.
At the same time that these immune cells help the cancer, they also are suppressing the immune system.
>> Click here to read more.
Source: Ovarian Cancer Research Fund
Get Resources and Insights Straight To Your Inbox
Explore More Articles
The Future of Corporate Giving: How Nonprofits Can Prepare
Corporate giving is a valuable part of the nonprofit funding ecosystem. Companies large and small have incorporated philanthropic efforts into their overall business plans, from…
Read Article
Join Us at the Workplace Fundraising & Volunteering Summit!
We’re excited to announce that America’s Charities President, Jim Starr, and Board Member, Fernando Lorence of JP Morgan Chase, will be speaking at the Workplace…
Read Article
Breast Cancer Awareness Month
October is Breast Cancer Awareness Month – an annual campaign that aims to educate the public on the importance of early screening, testing and treatment for…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
